Angiology
Vena cava filter that is long-duration and temporary is safe and effective
Published in Hematology Week, August 7th, 2006
According to a study from France, "Nonpermanent caval filters are placed in critical thromboembolic situations in which anticoagulation therapy is transiently contraindicated, ineffective, or the source of complications. The purpose of this study was to assess the safety and effectiveness of a second-generation long-duration temporary caval filter in these situations and compare its utility with that of other temporary filters."
G. Bovyn and colleagues, University Hospital Jean Bernard, wrote, "This prospective study,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2006-08-07)
More Articles from Hematology Week
- Chronic Myeloid Leukemia
Dasatinib targets earlier progenitors than imatinib in primary chronic myeloid leukemia - Hematology
Peripheral artery disease patients improve lipid control with pharmacist-based management - Leukemia
Childhood leukemia risk linked to birth weight and maternal weight - Multiple Myeloma Therapy
Thalidomide analogue-induced neutropenia in multiple myeloma is linked to increase in neutrophils bearing CD64 - Peripheral Blood
Donor peripheral blood enriched for memory TCD8+ cells compared to bone marrow grafts - Adverse Drug Reaction
Severe liver disease is associated with prolonged antiretroviral drug exposure - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
